Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NADROPARIN vs NAFTIFINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NADROPARIN vs NAFTIFINE: Safety Overview

Metric NADROPARIN NAFTIFINE
Total FAERS Reports 676 121
Deaths Reported 57 0
Death Rate 8.4% N/A
Hospitalizations 355 5
Average Patient Age 56.3 yrs 59.7 yrs
% Female Patients 58.5% 55.5%
FDA Approval Date N/A Apr 10, 2017
Manufacturer N/A Sun Pharmaceutical Industries, Inc.
Route N/A TOPICAL
Marketing Status N/A Prescription